Nothing Special   »   [go: up one dir, main page]

TWI787298B - Thioether derivatives of dibenzothiophene and dibenzofuran - Google Patents

Thioether derivatives of dibenzothiophene and dibenzofuran Download PDF

Info

Publication number
TWI787298B
TWI787298B TW107122722A TW107122722A TWI787298B TW I787298 B TWI787298 B TW I787298B TW 107122722 A TW107122722 A TW 107122722A TW 107122722 A TW107122722 A TW 107122722A TW I787298 B TWI787298 B TW I787298B
Authority
TW
Taiwan
Prior art keywords
formula
group
compound
atoms
compounds
Prior art date
Application number
TW107122722A
Other languages
Chinese (zh)
Other versions
TW201906830A (en
Inventor
拉斯 里耶佐
艾奇 高姿
哈拉德 賀奇曼
馬丁 安棋
Original Assignee
德商馬克專利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德商馬克專利公司 filed Critical 德商馬克專利公司
Publication of TW201906830A publication Critical patent/TW201906830A/en
Application granted granted Critical
Publication of TWI787298B publication Critical patent/TWI787298B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to 4,6-dihalodibenzothiophene and 4,6-dihalodibenzofuran 3-thioether derivatives of the formula I
Figure 107122722-A0101-11-0001-2
in which W, X, R1 , R2 , A1 , Z1 and m are as defined in Claim 1, to the preparation thereof, to the use thereof as components in liquid-crystalline media, and to electro-optical display elements which contain the liquid-crystalline media according to the invention.

Description

二苯并噻吩及二苯并呋喃的硫醚衍生物Sulfide Derivatives of Dibenzothiophene and Dibenzofuran

本發明係關於4,6-二鹵代二苯并噻吩及4,6-二鹵代二苯并呋喃3-硫醚衍生物、其製備方法、包含該等衍生物之液晶介質及含有該等液晶介質之光電顯示元件。該等化合物具有負介電各向異性。The present invention relates to 4,6-dihalogenated dibenzothiophene and 4,6-dihalogenated dibenzofuran 3-sulfide derivatives, their preparation methods, liquid crystal media containing these derivatives, and liquid crystal media containing these Optoelectronic display elements of liquid crystal media. These compounds have negative dielectric anisotropy.

已發現液晶具有廣泛應用領域,此乃因最早之市售可用液晶化合物係在約30年前發現的。特定而言,習用混合物之已知應用領域係用於表及口袋型計算器之顯示器,以及如用於火車站、機場及運動競技場中之大顯示面板。其他應用領域為可攜式電腦及桌上型電腦、導航系統及視訊應用之顯示器。對於最後提及之應用而言,特定而言,對反應時間及影像對比有甚高要求。Liquid crystals have found wide application because the first commercially available liquid crystal compounds were discovered about 30 years ago. In particular, known fields of application for customary mixtures are displays for watches and pocket calculators, and large display panels such as are used in railway stations, airports and sports arenas. Other areas of application are monitors for portable and desktop computers, navigation systems and video applications. For the last-mentioned applications, in particular, very high requirements are placed on the response time and image comparison.

液晶中之分子空間排列意指使其許多性質具有方向依賴性。對於本文中液晶顯示器中之使用重要的是,特定而言光學、介電及彈性機械行為中之各向異性。端視分子是否以其垂直或平行於電容器之兩個板之縱軸定向而定,其將具有不同電容;因此,液晶介質之介電常數ε對於兩個定向係不同的。在分子之縱軸與電容器板垂直定向之情形下的介電常數大於平行排列情形的物質稱為介電正性。換言之: 若平行於分子之縱軸之介電常數ε|| 大於垂直於分子之縱軸之介電常數ε ,則介電各向異性Dε = ε|| - ε 大於零。用於習用顯示器中之大部分液晶屬此組。The spatial arrangement of molecules in liquid crystals means that many of their properties are directionally dependent. Important for the use herein in liquid crystal displays is, in particular, anisotropy in optical, dielectric and elastomechanical behavior. Depending on whether the molecules are oriented perpendicular or parallel to the longitudinal axes of the two plates of the capacitor, they will have different capacitances; thus, the dielectric constant ε of the liquid crystal medium is different for the two orientations. A substance whose dielectric constant is greater in the case where the longitudinal axis of the molecules are oriented perpendicular to the capacitor plates than in the case of a parallel arrangement is called dielectrically positive. In other words: If the permittivity ε || parallel to the longitudinal axis of the molecule is greater than the permittivity ε perpendicular to the longitudinal axis of the molecule, then the dielectric anisotropy Dε = ε || - ε is greater than zero. Most liquid crystals used in conventional displays belong to this group.

分子之極化性亦及永久偶極距二者對介電各向異性皆起作用。在將電壓施加至顯示器時,分子之縱軸自我定向,以使得介電常數中較大者變得有效。與電場之相互作用強度此處取決於兩個常數之間之差。Both the polarizability of the molecule and the permanent dipole moment contribute to the dielectric anisotropy. When a voltage is applied to the display, the longitudinal axes of the molecules orient themselves so that the larger of the dielectric constants becomes effective. The strength of the interaction with the electric field depends here on the difference between two constants.

在用於習用液晶顯示器之液晶分子之情形下,沿分子之縱軸定向之偶極距大於與分子之縱軸垂直定向之偶極距。In the case of liquid crystal molecules used in conventional liquid crystal displays, the dipole moment oriented along the longitudinal axis of the molecule is greater than the dipole moment oriented perpendicular to the longitudinal axis of the molecule.

使用其中較大偶極距係平行於分子之縱軸定向之液晶,已研發極高性能顯示器。此處主要使用5至20種組分之混合物,以爭取中間相之足夠寬的溫度範圍以及短的反應時間及低的臨時電壓。然而,如針對(例如)膝上型電腦所使用之液晶顯示器情形下之強視角依賴性仍造成了困難。若顯示器區域與觀察者之視向垂直,則可達成最佳影像品質。若顯示器相對於視向傾斜,則在某些情況下影像品質急劇劣化。為了更大的舒適性,努力製造顯示器可自觀察者之視向傾斜之角度,而儘可能不會顯著降低影像品質。最近已試圖使用與分子之縱軸垂直之偶極距大於與分子之縱軸平行之偶極距的液晶化合物來改良視角依賴性。在此情形中,介電各向異性Δε係負的。在無場狀態下,該等分子係以其縱軸與顯示器之玻璃表面垂直定向。施加電場使其或多或少與玻璃表面平行地自我定向。以此方式,可達成視角依賴性之改良。此類型之顯示器稱為VA-TFT顯示器(源自英語: 「垂直排列」)。Using liquid crystals in which the larger dipole moment is oriented parallel to the longitudinal axis of the molecule, very high performance displays have been developed. Mixtures of 5 to 20 components are mainly used here in order to achieve a sufficiently wide temperature range of the mesophase as well as short reaction times and low temporary voltages. However, the strong viewing angle dependence as in the case of liquid crystal displays used for eg laptop computers still poses difficulties. The best image quality is achieved if the display area is perpendicular to the viewer's viewing direction. If the display is tilted with respect to the viewing direction, the image quality may be drastically degraded in some cases. For greater comfort, efforts have been made to make the display tiltable from the viewer's viewing angle without significantly degrading the image quality as much as possible. Recently attempts have been made to improve viewing angle dependence using liquid crystal compounds having a larger dipole moment perpendicular to the longitudinal axis of the molecule than parallel to the longitudinal axis of the molecule. In this case, the dielectric anisotropy Δε is negative. In the field-free state, the molecules are oriented with their longitudinal axes perpendicular to the glass surface of the display. Applying an electric field causes it to orient itself more or less parallel to the glass surface. In this way, an improvement in viewing angle dependence can be achieved. This type of display is called a VA-TFT display (from English: "Vertical Alignment").

液晶材料領域之發展尚有很長的路未完成。為改良液晶顯示元件之性質,不斷地努力研發能夠使該等顯示器最佳化之新穎化合物。The development of liquid crystal materials still has a long way to go. In order to improve the properties of liquid crystal display elements, efforts are constantly being made to develop novel compounds that can optimize these displays.

文件EP 2937342、WO 02/055463、DE 102005012585及EP 1752510揭示用作液晶材料之二苯并噻吩衍生物。該等化合物與本發明化合物在二苯并噻吩結構之取代方面不同。文件EP 2921487揭示作為液晶材料之二苯并呋喃衍生物。引文中未揭示環系統之位置3中之硫醚。Documents EP 2937342, WO 02/055463, DE 102005012585 and EP 1752510 disclose dibenzothiophene derivatives for use as liquid crystal materials. These compounds differ from the compounds of the present invention in the substitution of the dibenzothiophene structure. Document EP 2921487 discloses dibenzofuran derivatives as liquid crystal materials. The thioether in position 3 of the ring system is not disclosed in the citation.

本發明之目的係提供具有對於在液晶介質中使用有利之性質之化合物。特定而言,其應具有負介電各向異性,此使其尤其適用於VA顯示器之液晶介質。無論與顯示器類型相對應之介電各向異性如何,期望具有應用相關參數之有利組合之化合物。在欲同時最佳化之該等參數中,特定而言提及高澄清點、低旋轉黏度、在應用範圍內之光學各向異性及用於達成在寬溫度範圍內具有期望液晶相之混合物之性質(低熔點、與期望種類之其他液晶組分之良好混溶性)。It was an object of the present invention to provide compounds having advantageous properties for use in liquid-crystalline media. In particular, they should have negative dielectric anisotropy, which makes them especially suitable for use as liquid-crystalline media for VA displays. Regardless of the dielectric anisotropy corresponding to the display type, compounds with an advantageous combination of application-related parameters are desired. Among the parameters to be optimized at the same time, mention is made in particular of high clearing points, low rotational viscosities, optical anisotropy in the range of applications and for achieving mixtures with the desired liquid-crystalline phases over a broad temperature range. Properties (low melting point, good miscibility with other liquid crystal components of the desired kind).

此目的係根據本發明藉由通式I化合物來達成

Figure 02_image007
其中 X 獨立地表示F或Cl,較佳F, W 表示S或O,較佳S, m 表示0、1或2,較佳0, R1 及R2 彼此獨立地表示具有1至15個C原子之烷基或烷氧基,其中另外該等基團中之一或多個CH2 基團在每一情形下彼此分別獨立以O原子並不直接彼此連接之方式經-C≡C-、-CF2 O-、-OCF2 -、-CH=CH-、
Figure 02_image009
Figure 02_image011
Figure 02_image013
Figure 02_image015
、-O-、-S-、-CO-O-或-O-CO-置換,且其中另外一或多個H原子可經鹵素置換, 較佳彼此獨立地表示具有1至15個碳原子之未經取代烷基或烷氧基或具有2至15個C原子之烯基、烯基氧基或炔基,其在每一情形下視情況經單鹵化或多鹵化, A1 在每一情形下獨立地表示選自以下之群之基團: a) 1,4-伸苯基,其中另外一或兩個CH基團可經N置換且其中另外一或多個H原子可經基團L置換, b) 由反式-1,4-伸環己基及1,4-伸環己烯基組成之群,其中另外一或多個不相鄰CH2 基團可經-O-及/或-S-置換且其中另外一或多個H原子可經F或Cl置換,及 c) 由四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、四氫呋喃-2,5-二基、環丁烷-1,3-二基、六氫吡啶-1,4-二基、噻吩-2,5-二基及硒吩-2,5-二基組成之群,其另外可經基團L單取代或多取代, L 在每次出現時獨立地表示F、Cl、CN、SCN、SF5 或具有1至12個或較佳1至4個C原子之直鏈或具支鏈之在每一情形中視需要經氟化之烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰基氧基或烷氧基羰基氧基,且 Z1 彼此獨立地表示單鍵、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-(CO)O-、-O(CO)-、-(CH2 )4 -、-CH2 CH2 -、-CF2 -CF2 -、-CF2 -CH2 -、-CH2 -CF2 -、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-(CH2 )3 O-、-O(CH2 )3 -、-CºC-、-O-、-CH2 -、-(CH2 )3 -或-CF2 -。This object is achieved according to the invention by compounds of general formula I
Figure 02_image007
Wherein X independently represents F or Cl, preferably F, W represents S or O, preferably S, m represents 0, 1 or 2, preferably 0, R 1 and R 2 independently represent 1 to 15 C Alkyl or alkoxy groups of atoms, wherein one or more CH2 groups in these other groups are in each case independently of each other through -C≡C-, -CF 2 O-, -OCF 2 -, -CH=CH-,
Figure 02_image009
,
Figure 02_image011
,
Figure 02_image013
,
Figure 02_image015
, -O-, -S-, -CO-O- or -O-CO-, and wherein one or more H atoms can be replaced by halogens, preferably independently of each other representing a group having 1 to 15 carbon atoms Unsubstituted alkyl or alkoxy or alkenyl, alkenyloxy or alkynyl groups having 2 to 15 C atoms, which are in each case monohalogenated or polyhalogenated, A 1 in each case independently represents a group selected from the following group: a) 1,4-phenylene, wherein another one or two CH groups can be replaced by N and wherein another one or more H atoms can be replaced by a group L Substitution, b) the group consisting of trans-1,4-cyclohexylene and 1,4-cyclohexenyl, wherein one or more non-adjacent CH groups can be replaced by -O- and/or -S-substituted and wherein one or more additional H atoms may be replaced by F or Cl, and c) from tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl , tetrahydrofuran-2,5-diyl, cyclobutane-1,3-diyl, hexahydropyridine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl The group consisting of, which may additionally be monosubstituted or polysubstituted by a group L, L independently at each occurrence represents F, Cl, CN, SCN, SF 5 or has 1 to 12 or preferably 1 to 4 C straight-chain or branched, optionally fluorinated alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy in each case, and Z 1 each independently represents a single bond, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -(CO)O-, -O(CO)-, -(CH 2 ) 4 -, -CH 2 CH 2 -, -CF 2 -CF 2 -, -CF 2 -CH 2 -, -CH 2 -CF 2 -, -CH=CH-, -CF=CF-, -CF=CH- , -CH=CF-, -(CH 2 ) 3 O-, -O(CH 2 ) 3 -, -CºC-, -O-, -CH 2 -, -(CH 2 ) 3 -, or -CF 2 - .

該等化合物具有明顯負的Δε且因此特定而言適於在用於VA-TFT顯示器之液晶混合物中使用。本發明化合物較佳具有Δε ≤ -4、更佳Δε ≤ -7且尤佳Δε ≤ -9。其展現與在用於顯示器之液晶混合物中所使用之習用物質的良好混溶性,即該等化合物在該等習用物質中具有良好溶解性。化合物及所得液晶混合物之旋轉黏度有利地較小,不會同時顯著降低混合物之澄清點。These compounds have a clearly negative Δε and are therefore particularly suitable for use in liquid-crystal mixtures for VA-TFT displays. Compounds of the invention preferably have Δε ≤ -4, more preferably Δε ≤ -7 and especially preferably Δε ≤ -9. They exhibit good miscibility with customary substances used in liquid crystal mixtures for displays, ie the compounds have good solubility in these customary substances. The rotational viscosities of the compounds and of the resulting liquid-crystalline mixtures are advantageously low without at the same time significantly lowering the clearing point of the mixture.

本發明化合物之其他物理、物理化學或光電參數亦有利於於在液晶介質中使用該等化合物。特定而言,包含該等化合物之液晶介質具有足夠的向列相寬度及良好的低溫與長期穩定性,及足夠高之澄清點。本發明化合物之熔點低表示有利於混合過程。此外,根據本發明之式I化合物具有尤其適用於VA-TFT顯示器之光學各向異性Δn值。較佳地,本發明化合物具有大於0.15且小於0.25之Δn。此外,該等化合物相當容易製備。該等有利性質之平衡組合代表顯著富集可用於VA混合物之混合組分。Other physical, physicochemical or optoelectronic parameters of the compounds according to the invention also facilitate the use of these compounds in liquid-crystalline media. In particular, liquid-crystalline media comprising these compounds have sufficient nematic width and good low-temperature and long-term stability, and a sufficiently high clearing point. The low melting points of the compounds of the invention indicate that the mixing process is facilitated. Furthermore, the compounds of the formula I according to the invention have optical anisotropy Δn values which are particularly suitable for use in VA-TFT displays. Preferably, the compounds of the invention have a Δn greater than 0.15 and less than 0.25. Furthermore, these compounds are relatively easy to prepare. A balanced combination of these favorable properties represents a significant enrichment of blending components available for VA blends.

決定相鄰環系A1 之數目之參數m較佳具有0或1、特定而言0之值。The parameter m which determines the number of adjacent ring systems A 1 preferably has the value 0 or 1, in particular 0.

R1 在每一情形下彼此獨立地較佳表示分別具有1至7或2至7個碳原子之烷氧基、烷基或烯基。通式I中之R1 尤佳係具有2至7個C原子之烷氧基或烷基。R 1 preferably represents in each case independently of one another an alkoxy, alkyl or alkenyl group each having 1 to 7 or 2 to 7 carbon atoms. R 1 in general formula I is especially preferably an alkoxy group or an alkyl group having 2 to 7 C atoms.

R2 較佳表示分別具有1至7或2至7個碳原子之烷基或烯基。通式I中之R2 尤佳係具有2至7個C原子之烷基。R 2 preferably represents an alkyl or alkenyl group having 1 to 7 or 2 to 7 carbon atoms, respectively. R 2 in general formula I is especially preferably an alkyl group having 2 to 7 C atoms.

對於m = 0之情形,R1 較佳表示烷氧基、烷基或烯基、尤佳具有1至7個C原子、尤佳具有2至5個C原子之烷氧基。R1 及R2 中之碳原子數之總和一起較佳為4、5、6、7、8、9或10,尤佳6、7、8、9或10。For the case of m=0, R preferably represents an alkoxy group, an alkyl group or an alkenyl group, especially preferably an alkoxy group having 1 to 7 C atoms, especially preferably having 2 to 5 C atoms. The total number of carbon atoms in R 1 and R 2 is preferably 4, 5, 6, 7, 8, 9 or 10, especially preferably 6, 7, 8, 9 or 10.

對於m = 1或2之情形,R1 較佳表示具有1至7個C原子、尤佳具有2至7個C原子之烷基、烷氧基或烯基、尤佳烷基。For the case of m= 1 or 2, R preferably represents an alkyl, alkoxy or alkenyl group, especially preferably an alkyl group, having 1 to 7 C atoms, especially preferably having 2 to 7 C atoms.

若式I中之R1 及R2 在每一情形下彼此獨立地代表烷基,則該等基團為直鏈或具支鏈。該等基團中每一者較佳為直鏈,且除非另有說明,否則具有1、2、3、4、5、6或7個C原子且因此較佳為甲基、乙基、丙基、丁基、戊基、己基或庚基。If R 1 and R 2 in formula I each independently represent an alkyl group, these groups are straight-chain or branched. Each of these groups is preferably straight chain and, unless otherwise stated, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is therefore preferably methyl, ethyl, propyl base, butyl, pentyl, hexyl or heptyl.

若式I中之R1 在每一情形下彼此獨立地代表烷氧基,則此係直鏈或具支鏈。該等基團中每一者較佳為直鏈,且除非另有說明,否則具有1、2、3、4、5、6或7個C原子且因此較佳為甲氧基、乙氧基、丙氧基、丁氧基、戊氧基、己氧基或庚氧基。If R 1 in formula I each independently of the other represent alkoxy, this is straight-chain or branched. Each of these groups is preferably straight chain and, unless otherwise stated, has 1, 2, 3, 4, 5, 6 or 7 C atoms and is therefore preferably methoxy, ethoxy , propoxy, butoxy, pentyloxy, hexyloxy or heptyloxy.

此外,式I中之R1 及R2 在每一情形下可彼此獨立地為直鏈或具支鏈且具有至少一個C-C雙鍵之具有2至15個C原子之烯基。其較佳無支鏈且具有2至7個C原子。因此,其較佳係乙烯基、丙-1-或-2-烯基、丁-1-、-2-或-3-烯基、戊-1-、-2-、-3-或-4-烯基、己-1-、-2-、-3-、-4-或-5-烯基或庚-1-、-2-、-3-、-4-、-5-或-6-烯基。若C-C雙鍵之兩個C原子經取代,則烯基可以E及/或Z異構物(反式/順式)之形式存在。一般而言,各別E異構物較佳。在烯基中,尤佳者係丙-2-烯基、丁-2-或-3-烯基及戊-3-或-4-烯基。Furthermore, R 1 and R 2 in formula I may in each case independently of one another be straight-chain or branched alkenyl having 2 to 15 C atoms and having at least one CC double bond. It is preferably unbranched and has 2 to 7 C atoms. Therefore, it is preferably vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4 -enyl, hex-1-, -2-, -3-, -4- or -5-enyl or hept-1-, -2-, -3-, -4-, -5- or -6 -alkenyl. If the two C atoms of the CC double bond are substituted, the alkenyl group can exist in the form of E and/or Z isomers (trans/cis). In general, the respective E isomers are preferred. Among alkenyl groups, especially preferred are prop-2-enyl, but-2- or -3-enyl and pent-3- or -4-enyl.

式I中之R1 及R2 亦可彼此獨立地為直鏈或具支鏈的且具有至少一個C-C三鍵之具有2至15個C原子之炔基。較佳者係1-或2-丙炔基及1-、2-或3-丁炔基。R 1 and R 2 in formula I may also independently of each other be a linear or branched alkynyl group having 2 to 15 C atoms and having at least one CC triple bond. Preferred are 1- or 2-propynyl and 1-, 2- or 3-butynyl.

基團A1 獨立地較佳表示選自下式之二取代之環狀基團

Figure 02_image017
Figure 02_image019
Group A independently preferably represents a disubstituted cyclic group selected from the following formula
Figure 02_image017
Figure 02_image019

基團Z1 較佳表示單鍵、-CH2 O-、-CF2 O-或-OCF2 -,尤佳單鍵。The group Z 1 preferably represents a single bond, -CH 2 O-, -CF 2 O- or -OCF 2 -, especially preferably a single bond.

基團L較佳表示F、Cl、-CF3 或具有1、2或3個碳原子之烷基或烷氧基。The group L preferably represents F, Cl, —CF 3 or an alkyl or alkoxy group having 1, 2 or 3 carbon atoms.

尤佳地,m表示0且R1 表示具有1至7個碳原子之烷氧基。Especially preferably, m represents 0 and R 1 represents an alkoxy group having 1 to 7 carbon atoms.

結合本發明,鹵素表示氟、氯、溴或碘,較佳氟、氯或溴,且特定而言氟或氯。In connection with the present invention, halogen denotes fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine, and in particular fluorine or chlorine.

結合本發明,表達「烷基」除非在本說明書中或在申請專利範圍中其他地方不同地定義否則表示具有1至15個(即1個、2個、3個、4個、5個、6個、7個、8個、9個、10個、11個、12個、13個、14個或15個)碳原子之直鏈或具支鏈、飽和、脂肪族烴基團。In conjunction with the present invention, the expression "alkyl" means that there are 1 to 15 (i.e. 1, 2, 3, 4, 5, 6 1, 7, 8, 9, 10, 11, 12, 13, 14 or 15) carbon atoms straight-chain or branched, saturated, aliphatic hydrocarbon group.

根據本發明之式I化合物尤佳選自子式IA至IF

Figure 02_image021
Figure 02_image023
其中R1 、R2 及A1 具有如上文針對式I所定義之含義,且 Z1 係如上文針對式I所定義之無單鍵之基團。Compounds of formula I according to the invention are preferably selected from sub-formulas IA to IF
Figure 02_image021
Figure 02_image023
wherein R 1 , R 2 and A 1 have the meanings as defined above for formula I, and Z 1 is a group without a single bond as defined above for formula I.

較佳之式IA及ID化合物係式IA-1至IA-3及ID-1至ID-3化合物,

Figure 02_image025
Figure 02_image027
其中烷基及烷基*彼此獨立地表示具有1至7個C原子之直鏈烷基且烷氧基獨立地表示具有1至7個C原子之直鏈烷氧基。尤佳者係式IA-1化合物。Preferred compounds of formula IA and ID are compounds of formula IA-1 to IA-3 and ID-1 to ID-3,
Figure 02_image025
Figure 02_image027
wherein alkyl and alkyl* independently represent straight-chain alkyl having 1 to 7 C atoms, and alkoxy independently represent straight-chain alkoxy having 1 to 7 C atoms. Most preferred are compounds of formula IA-1.

較佳之式IB及IC化合物係下式之化合物:

Figure 02_image029
Figure 02_image031
其中烷基彼此獨立地表示具有1至7個C原子之直鏈烷基。Preferred compounds of formula IB and IC are compounds of the formula:
Figure 02_image029
Figure 02_image031
wherein the alkyl groups independently represent straight-chain alkyl groups having 1 to 7 C atoms.

尤佳之式I或IA-1化合物係選自式IA-1-1至IA-1-26之彼等化合物:

Figure 02_image033
Figure 02_image035
Figure 02_image037
Figure 02_image039
若本發明化合物之基團或取代基或本發明化合物本身係以光學活性或立體異構物基團、取代基或化合物之形式存在(此乃因(例如)其具有不對稱中心),則該等同樣涵蓋於本發明中。在此不言而喻,本發明之通式I化合物可以異構純形式、例如以純鏡像異構物、非鏡像異構物、E或Z異構物、反式或順式異構物形式、或以任何期望比率之複數種異構物之混合物形式、例如以外消旋物、E/Z異構物混合物形式或以順式/反式異構物混合物形式存在。A particularly preferred compound of formula I or IA-1 is selected from those compounds of formula IA-1-1 to IA-1-26:
Figure 02_image033
Figure 02_image035
Figure 02_image037
Figure 02_image039
If a group or substituent of a compound of the invention or a compound of the invention itself exists as an optically active or stereoisomer group, substituent or compound because, for example, it has an asymmetric center, then the etc. are also included in the present invention. It goes without saying here that the compounds of the general formula I according to the invention may be in isomerically pure form, for example in the form of pure enantiomers, diastereoisomers, E or Z isomers, trans or cis isomers, Or as a mixture of several isomers in any desired ratio, for example as a racemate, as a mixture of E/Z isomers or as a mixture of cis/trans isomers.

用於液晶介質之所揭示化合物中之式

Figure 02_image041
或-Cyc-之1,4-取代之環己基環 較佳具有反式構形,即位於熱力學上較佳之椅形構象之兩個取代基二者皆在赤道位。Among the disclosed compounds for use in liquid crystal media is the formula
Figure 02_image041
The 1,4-substituted cyclohexyl ring of -Cyc- or -Cyc- preferably has a trans configuration, ie both substituents are in the thermodynamically preferred chair conformation with both at the equator.

通式I化合物可藉由本身已知之方法,如文獻(例如標準著作,例如Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart)中所述,且具體而言在已知且適於指定反應之反應條件下合成。就此而言,可利用本文未更詳細提及之本身已知之變體。Compounds of general formula I can be obtained by methods known per se, as described in the literature (e.g. standard works, e.g. Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), and in particular Said to be synthesized under known and suitable reaction conditions for the given reaction. In this connection, per se known variants which are not mentioned in more detail here can be utilized.

起始材料亦可視情況原位形成,使得其未自反應混合物分離,而是立刻進一步反應以得到通式I化合物。The starting material may also optionally be formed in situ, so that it is not isolated from the reaction mixture, but reacted further immediately to give the compound of general formula I.

在實例中以舉例方式闡述本發明通式I化合物之合成。起始物質可藉由通常可及之文獻程序獲得或市售獲得。The synthesis of compounds of general formula I according to the invention is illustrated in the examples. Starting materials can be obtained by commonly available literature procedures or obtained commercially.

本發明化合物之尤其適宜之合成途徑在下文中參照方案進行解釋。以下方案中之取代基R1 、R2 、X、W及指數m具有如針對式I所給出之含義。Particularly suitable synthetic routes for the compounds of the invention are explained below with reference to the schemes. The substituents R 1 , R 2 , X, W and the index m in the following schemes have the meanings as given for formula I.

式I化合物(其中W = S且m = 0)之合成根據方案1自基本化合物開始。

Figure 02_image043
方案 1 . 二苯并噻吩之實例合成. R1 = -OR,m = 0。The synthesis of compounds of formula I (where W = S and m = 0) starts from basic compounds according to Scheme 1 .
Figure 02_image043
Scheme 1. Example synthesis of dibenzothiophene. R 1 = -OR, m = 0.

相應二氟二苯并呋喃化合物(W = O,m = 0)之合成闡述於(例如)公開案US 2015/0259602 A1中。

Figure 02_image045
方案 2. 式I化合物之兩種替代合成途徑. 類似地定義取代基。The synthesis of the corresponding difluorodibenzofuran compounds (W=0, m=0) is described, for example, in publication US 2015/0259602 A1.
Figure 02_image045
Scheme 2. Two Alternative Synthetic Routes for Compounds of Formula I. The substituents are similarly defined.

所繪示之反應方案僅視為實例。視情況,通常亦可類似地向通式I引入式R1 -[A1 -Z1 ]m -之基團來代替方案1中之基團-OR。熟習此項技術者可對所提出之合成進行相應改變,以及尋找其他適宜合成途徑以獲得式I化合物。The depicted reaction schemes are considered as examples only. Optionally, a group of the formula R 1 -[A 1 -Z 1 ] m - can also be similarly introduced into the general formula I to replace the group -OR in scheme 1. Those skilled in the art can make corresponding changes to the proposed syntheses and find other suitable synthetic routes to obtain the compounds of formula I.

根據上文所示之合成,本發明在一個實施例中亦包括一或多種製備式I化合物之方法。The invention also includes, in one embodiment, one or more methods of preparing compounds of formula I, based on the syntheses shown above.

因此,本發明涵蓋式I化合物之製備方法,其特徵在於其包括如下過程步驟:其中使式(B)化合物

Figure 02_image047
其中W、X、Z1 、A1 、m及R1 係獨立地如式I中所定義, 在OH基團與三氟甲磺酸或其反應性衍生物反應,以得到式(C)化合物
Figure 02_image049
其中獨立地 OTf 表示基團O(SO2 )CF3 , 且 W、X、Z1 、A1 、m及R1 係獨立地如式I中、特定而言如針對式(B)所定義, 且在一或多個其他方法步驟中轉化成式I化合物。Therefore, the present invention covers a process for the preparation of compounds of formula I, characterized in that it comprises the following process steps: wherein the compound of formula (B)
Figure 02_image047
wherein W, X, Z 1 , A 1 , m and R 1 are independently as defined in formula I, where the OH group is reacted with trifluoromethanesulfonic acid or a reactive derivative thereof to obtain a compound of formula (C)
Figure 02_image049
wherein independently OTf represents the group O(SO 2 )CF 3 , and W, X, Z 1 , A 1 , m and R 1 are independently as defined in formula I, in particular for formula (B), and converted to a compound of formula I in one or more further process steps.

用三氟甲磺酸(衍生物)酯化式(B)化合物之OH基團較佳利用三氟甲磺醯氯(TfCl)或三氟甲烷磺酸酐(TfOTf)實施。Esterification of the OH group of the compound of formula (B) with trifluoromethanesulfonic acid (derivative) is preferably carried out using trifluoromethanesulfonyl chloride (TfCl) or trifluoromethanesulfonic anhydride (TfOTf).

所揭示之過程步驟及反應混合物之後處理原則上可以間歇反應或以連續反應模式實施。連續反應模式包括(例如)在連續攪拌罐反應器、攪拌罐級聯、環流或錯流反應器、流量管或微反應器中之反應。反應混合物之處理係視情況視需要藉由經由固相過濾、層析、分離不混溶相(例如萃取)、吸附至固體支撐物上、蒸餾性移除溶劑及/或共沸混合物、選擇性蒸餾、昇華、結晶、共結晶或藉由經由膜奈米過濾實施。The disclosed process steps and work-up of the reaction mixture can in principle be carried out as a batch reaction or in continuous reaction mode. Continuous reaction modes include, for example, reactions in continuous stirred tank reactors, stirred tank cascades, loop or cross flow reactors, flow tubes, or microreactors. The reaction mixture is worked up, optionally by solid phase filtration, chromatography, separation of immiscible phases (e.g. extraction), adsorption onto a solid support, distillative removal of solvents and/or azeotropes, selective Distillation, sublimation, crystallization, co-crystallization or by nanofiltration through membranes.

如已提及,通式I化合物可用於液晶介質中。因此,本發明亦提供具有至少兩種液晶化合物之液晶介質,該至少兩種液晶化合物包含至少一種通式I化合物。As already mentioned, the compounds of the general formula I can be used in liquid-crystalline media. The invention therefore also provides liquid-crystalline media having at least two liquid-crystalline compounds comprising at least one compound of the general formula I.

本發明亦提供除本發明之一或多種式I化合物以外包含2至40種、較佳地4至30種組分作為其他成分之液晶介質。除本發明之一或多種化合物以外,該等介質尤佳包含7至25種組分。該等其他成分較佳係選自向列型或向列態(單態性或各向同性)物質、特定而言係來自以下類別之物質:氧偶氮苯、亞苄基苯胺、聯苯、聯三苯、1,3-二噁烷、2,5-四氫吡喃、苯甲酸苯基酯或苯甲酸環己基酯、環己烷羧酸苯基酯或環己烷羧酸環己基酯、環己基苯甲酸之苯基酯或環己基酯、環己基環己烷羧酸之苯基酯或環己基酯、苯甲酸、環己烷羧酸或環己基環己烷羧酸之環己基苯基酯、苯基環己烷、環己基聯苯、苯基環己基環己烷、環己基環己烷、1,4-雙環己基苯、4',4'-雙環己基聯苯、苯基嘧啶或環己基嘧啶、苯基吡啶或環己基吡啶、苯基二噁烷或環己基二噁烷、苯基-或環己基-1,3-二噻𠮿、1,2-二苯基乙烷、1,2-二環己基乙烷、1-苯基-2-環己基乙烷、1-環己基-2-(4-苯基環己基)乙烷、1-環己基-2-聯苯乙烷、1-苯基-2-環己基苯基乙烷、視情況鹵化二苯乙烯、苄基苯基醚、二苯乙炔及經取代肉桂酸。該等化合物中之1,4-伸苯基亦可經單氟化或多氟化。The invention also provides liquid-crystalline media which, in addition to one or more compounds of the formula I according to the invention, comprise as further constituents 2 to 40, preferably 4 to 30, components. These media preferably comprise 7 to 25 components in addition to one or more compounds according to the invention. These other constituents are preferably selected from nematic or nematic (monomorphic or isotropic) substances, in particular from the following classes: oxyazobenzene, benzylidene aniline, biphenyl, Terphenyl, 1,3-dioxane, 2,5-tetrahydropyran, phenyl benzoate or cyclohexyl benzoate, phenyl cyclohexanecarboxylate or cyclohexylcyclohexanecarboxylate , phenyl or cyclohexyl ester of cyclohexylbenzoic acid, phenyl or cyclohexyl ester of cyclohexylcyclohexanecarboxylic acid, benzoic acid, cyclohexanecarboxylic acid or cyclohexylbenzene of cyclohexylcyclohexanecarboxylic acid base ester, phenylcyclohexane, cyclohexylbiphenyl, phenylcyclohexylcyclohexane, cyclohexylcyclohexane, 1,4-bicyclohexylbenzene, 4',4'-bicyclohexylbiphenyl, phenylpyrimidine or cyclohexylpyrimidine, phenylpyridine or cyclohexylpyridine, phenyldioxane or cyclohexyldioxane, phenyl- or cyclohexyl-1,3-dithiarone, 1,2-diphenylethane, 1,2-Dicyclohexylethane, 1-phenyl-2-cyclohexylethane, 1-cyclohexyl-2-(4-phenylcyclohexyl)ethane, 1-cyclohexyl-2-biphenylethyl alkanes, 1-phenyl-2-cyclohexylphenylethane, optionally halogenated stilbenes, benzylphenyl ethers, tolans, and substituted cinnamic acids. The 1,4-phenylene groups in these compounds may also be monofluorinated or polyfluorinated.

適宜作為本發明介質之其他成分之最重要化合物可由式(II)、(III)、(IV)、(V)及(VI)來表徵: R'-L-E-R'' (II) R'-L-COO-E-R'' (III) R'-L-OOC-E-R'' (IV) R'-L-CH2 CH2 -E-R'' (V ) R'-L-CF2 O-E-R'' (VI) 在式(II)、(III)、(IV)、(V)及(VI)中,L及E可相同或不同,在每一情形下彼此獨立地表示來自由-Phe-、-Cyc-、-Phe-Phe-、-Phe-Cyc-、-Cyc-Cyc-、-Pyr-、-Dio-、-Thp-、-G-Phe-及-G-Cyc-及其鏡像形成之基團之二價基團,其中Phe表示未經取代或氟取代之1,4-伸苯基,Cyc表示反式-1,4-伸環己基或1,4-伸環己烯基,Pyr表示嘧啶-2,5-二基或吡啶-2,5-二基,Dio表示1,3-二噁烷-2,5-二基,Thp表示四氫吡喃-2,5-二基,且G表示2-(反式-1,4-環己基)乙基、嘧啶-2,5-二基、吡啶-2,5-二基、1,3-二噁烷-2,5-二基或四氫吡喃-2,5-二基。The most important compounds suitable as other components of the medium of the invention can be characterized by the formulas (II), (III), (IV), (V) and (VI): R'-LE-R'' (II) R'- L-COO-E-R'' (III) R'-L-OOC-E-R'' (IV) R'-L-CH 2 CH 2 -E-R'' ( V ) R'-L- CF 2 OE-R'' (VI) In formulas (II), (III), (IV), (V) and (VI), L and E may be the same or different, and in each case independently of each other represent Derived from -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Thp-, -G-Phe- and -G-Cyc - and the divalent group of the group formed by its mirror image, wherein Phe represents unsubstituted or fluorine-substituted 1,4-phenylene, Cyc represents trans-1,4-cyclohexyl or 1,4- Cyclohexenyl, Pyr means pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio means 1,3-dioxane-2,5-diyl, Thp means tetrahydropyran-2 ,5-diyl, and G represents 2-(trans-1,4-cyclohexyl)ethyl, pyrimidine-2,5-diyl, pyridine-2,5-diyl, 1,3-dioxane -2,5-diyl or tetrahydropyran-2,5-diyl.

基團L及E中之一者較佳為Cyc或Phe。E較佳為Cyc、Phe或Phe-Cyc。本發明介質較佳包含一或多種選自式(II)、(III)、(IV)、(V)及(VI)之化合物之組分,其中L及E係選自基團Cyc及Phe;且同時一或多種組分係選自式(II)、(III)、(IV)、(V)及(VI)之化合物,其中基團L及E中之一者係選自基團Cyc及Phe且另一基團係選自基團-Phe-Phe-、-Phe-Cyc-、-Cyc-Cyc-、-G-Phe-及-G-Cyc-;且視情況一或多種組分係選自式(II)、(III)、(IV)、(V)及(VI)之化合物,其中基團L及E係選自基團-Phe-Cyc-、-Cyc-Cyc-、-G-Phe-及-G-Cyc-。One of the groups L and E is preferably Cyc or Phe. E is preferably Cyc, Phe or Phe-Cyc. The medium of the present invention preferably comprises one or more components selected from the compounds of formulas (II), (III), (IV), (V) and (VI), wherein L and E are selected from the groups Cyc and Phe; And at the same time one or more components are selected from compounds of formula (II), (III), (IV), (V) and (VI), wherein one of the groups L and E is selected from the group Cyc and Phe and another group is selected from the group -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-; and optionally one or more components are Compounds selected from formulas (II), (III), (IV), (V) and (VI), wherein the groups L and E are selected from the group -Phe-Cyc-, -Cyc-Cyc-, -G -Phe- and -G-Cyc-.

式(II)、(III)、(IV)、(V)及(VI)化合物之相對較小亞組中之R'及R''在每一情形下彼此獨立地表示具有至多8個C原子之烷基、烯基、烷氧基、烷氧基烷基(氧雜烷基)、烯氧基或烷醯基氧基。此較小亞組在下文稱為組A,且該等化合物係由子式(IIa)、(IIIa)、(IVa)、(Va)及(VIa)提及。在大部分該等化合物之情形下,R'及R''彼此不同,其中該等基團中之一者在大部分情形下為烷基、烯基、烷氧基或烷氧基烷基(氧雜烷基)。R' and R'' in relatively small subgroups of compounds of formulas (II), (III), (IV), (V) and (VI) represent in each instance independently of each other having up to 8 C atoms Alkyl, alkenyl, alkoxy, alkoxyalkyl (oxaalkyl), alkenyloxy or alkyloxy. This smaller subgroup is hereinafter referred to as Group A, and the compounds are referred to by the subformulas (IIa), (IIIa), (IVa), (Va) and (VIa). In the case of most of these compounds, R' and R'' are different from each other, and one of these groups is in most cases an alkyl, alkenyl, alkoxy or alkoxyalkyl ( oxaalkyl).

在式(II)、(III)、(IV)、(V)及(VI)化合物之另一相對較小亞組(稱作組B)中,E表示

Figure 02_image051
。In another relatively small subgroup of compounds of formulas (II), (III), (IV), (V) and (VI), called group B, E represents
Figure 02_image051
.

在藉由子式(IIb)、(IIIb)、(IVb)、(Vb)及(VIb)提及之組B之化合物中,R'及R''具有在子式(IIa)至(VIa)之化合物情形下所給出示之含義且較佳地為烷基、烯基、烷氧基或烷氧基烷基(氧雜烷基)。In the compounds of group B mentioned by subformulas (IIb), (IIIb), (IVb), (Vb) and (VIb), R' and R'' have the The meanings given in the case of compounds are preferably alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).

在式(II)、(III)、(IV)、(V)及(VI)化合物之另一相對較小亞組中,R''表示-CN。此亞組在下文中稱作組C且此亞組之化合物相應地由子式(IIc)、(IIIc)、(IVc)、(Vc)及(VIc)闡述。在子式(IIc)、(IIIc)、(IVc)、(Vc)及(VIc)之化合物中,R'具有在子式(IIa)至(VIa)之化合物情形下所給出之含義且較佳為烷基、烯基、烷氧基或烷氧基烷基(氧雜烷基)。In another relatively small subgroup of compounds of formulas (II), (III), (IV), (V) and (VI), R'' represents -CN. This subgroup is hereinafter referred to as group C and the compounds of this subgroup are correspondingly illustrated by sub-formulas (IIc), (IIIc), (IVc), (Vc) and (VIc). In the compounds of the subformulas (IIc), (IIIc), (IVc), (Vc) and (VIc), R' has the meaning given in the case of the compounds of the subformulas (IIa) to (VIa) and is greater than Preferable is alkyl, alkenyl, alkoxy or alkoxyalkyl (oxaalkyl).

除組A、B及C之較佳化合物以外,具有所提出取代基之其他變體之式(II)、(III)、(IV)、(V)及(VI)之其他化合物亦常見。所有該等物質皆可藉由自文獻已知之方法或以與其類似之方法獲得。Besides the preferred compounds of groups A, B and C, other compounds of the formulas (II), (III), (IV), (V) and (VI) with other variants of the mentioned substituents are also common. All these substances can be obtained by methods known from the literature or in a manner analogous thereto.

除本發明之通式I化合物以外,本發明介質較佳包含一或多種來自組A、B及/或C之化合物。本發明介質中之來自該等組之化合物之重量分數為: 組A: 0%至90%、較佳20%至90%、特定而言30%至90%。 組B: 0%至80%、較佳10%至80%、特定而言10%至70%。 組C: 0%至80%、較佳5%至80%、特定而言5%至50%。The medium according to the invention preferably comprises, in addition to the compounds of general formula I according to the invention, one or more compounds from groups A, B and/or C. The weight fractions of compounds from these groups in the medium of the invention are: Group A: 0% to 90%, preferably 20% to 90%, in particular 30% to 90%. Group B: 0% to 80%, preferably 10% to 80%, in particular 10% to 70%. Group C: 0% to 80%, preferably 5% to 80%, in particular 5% to 50%.

本發明介質較佳包含1%至40%、特定而言5%至30%之本發明之式I化合物。介質較佳包含一種、兩種、三種、四種或五種本發明之式I化合物。The medium according to the invention preferably comprises from 1% to 40%, in particular from 5% to 30%, of a compound of formula I according to the invention. The medium preferably comprises one, two, three, four or five compounds of formula I according to the invention.

本發明之介質之製備係以本身常見之方式實施。通常,較佳在高溫下使組分互相溶解。可以藉助適宜添加劑修飾本發明之液晶相,使本發明之液晶相可用於迄今已知之所有種類之液晶顯示器元件。此類型添加劑為熟習此項技術者已知且詳細闡述於文獻(H. Kelker/ R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980)中。舉例而言,可添加用於產生有色客體-主體系統之多色性染料或用於改變向列相之介電各向異性、黏度及/或方向之物質。The preparation of the medium according to the invention is carried out in a manner customary per se. In general, it is preferred to dissolve the components in each other at elevated temperature. The liquid-crystalline phases according to the invention can be modified by means of suitable additives so that the liquid-crystalline phases according to the invention can be used in all types of liquid-crystal display elements known hitherto. Additives of this type are known to those skilled in the art and are described in detail in the literature (H. Kelker/R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, pleochroic dyes for creating colored guest-host systems or substances for changing the dielectric anisotropy, viscosity and/or orientation of the nematic phase can be added.

基於式I化合物之負Δε,尤其適用於VA-TFT顯示器。Based on the negative Δε of the compound of formula I, it is especially suitable for VA-TFT displays.

因此,本發明亦提供含有本發明液晶介質之光電顯示元件。顯示元件較佳係VA-TFT顯示元件(VA: 垂直排列;TFT:薄膜電晶體)。此外,存在同樣使用具有負介電各向異性之介質之其他類型之顯示元件。The invention therefore also provides optoelectronic display elements which comprise the liquid-crystal media according to the invention. The display element is preferably a VA-TFT display element (VA: Vertical Alignment; TFT: Thin Film Transistor). Furthermore, there are other types of display elements that also use media with negative dielectric anisotropy.

由申請專利範圍及此等申請專利範圍中之兩項或更多項之組合產生本發明之其他實施例。Other embodiments of the invention result from claimed claims and combinations of two or more of these claimed claims.

下文藉由參照工作實施例更詳細地說明本發明,然而,沒有任何限制本發明之意圖。熟習此項技術者將能夠自實例中推斷出一般說明中未具體給出的程序詳情,根據一般專業知識對其進行概括並將其應用於其特定目標。The invention is explained in more detail below by referring to working examples, however, without any intention of limiting the invention. Those skilled in the art will be able to deduce from the examples procedural details not specifically given in the general description, generalize them on the basis of general expertise and apply them to their specific objectives.

除常用及熟知之縮寫以外,使用以下縮寫: C:晶相;N:向列相;Sm:層列相; I:各向同性相。該等符號間之數字指示有關物質之轉變溫度。 除非另外陳述,否則溫度係以℃給出。In addition to commonly used and well-known abbreviations, the following abbreviations are used: C: crystalline phase; N: nematic phase; Sm: smectic phase; I: isotropic phase. The numbers between these symbols indicate the transition temperature of the relevant substance. Temperatures are given in °C unless otherwise stated.

物理、物理化學或光電參數係根據眾所周知方法測定,如尤其手冊「Merck Liquid Crystals - Licristal® - Physical Properties of Liquid Crystals - Description of the Measurements Methods」, 1998, Merck KGaA, Darmstadt中所述。The physical, physicochemical or optoelectronic parameters are determined according to known methods, as described inter alia in the handbook "Merck Liquid Crystals - Licristal® - Physical Properties of Liquid Crystals - Description of the Measurement Methods", 1998, Merck KGaA, Darmstadt.

上文及下文中,Δn表示光學各向異性(589 nm,20℃)且Δε表示介電各向異性(1 kHz,20℃)。介電各向異性Δε係於20℃及1 kHz下測定。光學各向異性∆n係於20℃及589.3 nm之波長下測定。Above and below, Δn denotes optical anisotropy (589 nm, 20°C) and Δε denotes dielectric anisotropy (1 kHz, 20°C). The dielectric anisotropy Δε was measured at 20°C and 1 kHz. The optical anisotropy ∆n is measured at 20°C and a wavelength of 589.3 nm.

本發明化合物之Δε及∆n值、外推澄清點(cl. p.)及旋轉黏度(γ1 )係藉由自由5%至10%之本發明之特定化合物及90%至95%之市售液晶混合物ZLI-2857 (針對Δε、cl. p.)或ZLI-4792 (針對∆n、γ1 ) (來自Merck KGaA,Darmstadt之混合物)組成之液晶混合物直線外推來獲得。The Δε and Δn values, extrapolated clearing point (cl.p.) and rotational viscosity (γ 1 ) of the compounds of the present invention are determined by free 5% to 10% of the specific compound of the present invention and 90% to 95% of the market value. It was obtained by linear extrapolation of liquid crystal mixtures composed of commercially available liquid crystal mixtures ZLI-2857 (for Δε, cl. p.) or ZLI-4792 (for ∆n, γ 1 ) (mixtures from Merck KGaA, Darmstadt).

於下文中,縮寫表示: MTB 甲基第三丁基醚 THF 四氫呋喃 DMAP 4-(二甲基胺基)吡啶 m.p. 熔點In the following, the abbreviations indicate: MTB methyl tertiary butyl ether THF tetrahydrofuran DMAP 4-(dimethylamino)pyridine m.p. melting point

實例 起始物質可藉由通常可及之文獻程序獲得或市售可得。 EXAMPLES Starting materials can be obtained by commonly available literature procedures or are available commercially.

實例 1 步驟 1

Figure 02_image053
將0.058 mol之2-溴-6-氟苯酚溶解於100 ml之THF中,並與40 ml之水及0.09 mol之碳酸鉀混合。在加熱至沸點後,添加0.3 mmol之參(二亞苄基丙酮)二鈀(0)及0.9 mmol之cataCXium® A (二(1-金剛烷基)-正丁基膦),並在半小時內逐滴添加0.062 mol之(4-乙氧基-2,3-二氟苯基)二甲氧基-硼烷溶解於100 ml之THF中之溶液。將混合物於回流溫度下再煮沸16小時,隨後與水及MTB混合並藉由萃取處理。藉由層析(溶析劑:氯丁烷)純化粗產物4'-乙氧基-3,2',3'-三氟聯苯-2-醇,從而得到白色晶體。 Example 1 Step 1
Figure 02_image053
0.058 mol of 2-bromo-6-fluorophenol was dissolved in 100 ml of THF and mixed with 40 ml of water and 0.09 mol of potassium carbonate. After heating to the boiling point, add 0.3 mmol of ginseng (dibenzylideneacetone) dipalladium (0) and 0.9 mmol of cataCXium® A (two (1-adamantyl)-n-butylphosphine), and in half an hour A solution of 0.062 mol of (4-ethoxy-2,3-difluorophenyl)dimethoxy-borane dissolved in 100 ml of THF was added dropwise. The mixture was boiled at reflux temperature for a further 16 hours, then mixed with water and MTB and worked up by extraction. The crude product 4'-ethoxy-3,2',3'-trifluorobiphenyl-2-ol was purified by chromatography (eluent: chlorobutane) to obtain white crystals.

步驟 2

Figure 02_image055
將0.022 mol之4'-乙氧基-3,2',3'-三氟聯苯-2-醇、0.036 mol之三乙胺及0.6 mmol之DMAP溶解於50 ml之二氯甲烷中。在5℃至10℃下在半小時內將0.03 mol之三氟甲磺酸酐逐滴添加至此溶液中。再將批料攪拌1小時,而不進一步冷卻,且利用二氯甲烷經由含有矽膠之管柱過濾。蒸發該濾液得到4'-乙氧基-3,2',3'-三氟聯苯-2-醇之三氟甲基磺酸酯。 step 2
Figure 02_image055
0.022 mol of 4'-ethoxy-3,2',3'-trifluorobiphenyl-2-ol, 0.036 mol of triethylamine and 0.6 mmol of DMAP were dissolved in 50 ml of dichloromethane. 0.03 mol of trifluoromethanesulfonic anhydride was added dropwise to this solution at 5°C to 10°C within half an hour. The batch was stirred for an additional hour without further cooling and filtered through a column containing silica gel with dichloromethane. Evaporation of the filtrate afforded the triflate of 4'-ethoxy-3,2',3'-trifluorobiphenyl-2-ol.

步驟 3

Figure 02_image057
將0.022 mol 4'-乙氧基-3,2',3'-三氟-聯苯-2-醇之三氟甲烷磺酸酯及0.024 mol之巰基丙酸乙酯溶解於50 ml之無水甲苯中並在回流溫度下與2.2 mmol之雙(2-二苯基膦基苯基)醚、1.1 mmol之參-(二亞苄基丙酮)二鈀(0)及0.055 mol之碳酸鉀一起煮沸24小時。將反應混合物與水及MTB混合並藉由萃取處理。濃縮有機相,並藉由管柱層析利用1-氯丁烷在矽膠上分離產物,從而得到0.014 mol之3-(4'-乙氧基-3,2',3'-三氟聯苯-2-基硫基)丙酸乙酯。 step 3
Figure 02_image057
Dissolve 0.022 mol of 4'-ethoxy-3,2',3'-trifluoro-biphenyl-2-ol trifluoromethanesulfonate and 0.024 mol of ethyl mercaptopropionate in 50 ml of anhydrous toluene and boil at reflux temperature with 2.2 mmol of bis(2-diphenylphosphinophenyl)ether, 1.1 mmol of ginseng-(dibenzylideneacetone)dipalladium(0) and 0.055 mol of potassium carbonate for 24 Hour. The reaction mixture was mixed with water and MTB and worked up by extraction. Concentrate the organic phase and separate the product by column chromatography on silica gel with 1-chlorobutane to give 0.014 mol of 3-(4'-ethoxy-3,2',3'-trifluorobiphenyl -2-ylthio)propionic acid ethyl ester.

步驟 4

Figure 02_image059
在回流溫度下將0.014 mol之3-(4'-乙氧基-3,2',3'-三氟聯苯-2-基硫基)丙酸乙酯與50 ml之THF中之0.017 mol第三丁醇鉀一起煮沸14小時。將反應混合物與水及MTB混合並藉由萃取處理。濃縮有機相,並藉由管柱層析利用1-氯丁烷在矽膠上分離產物,從而得到3-乙氧基-4,6-二氟二苯并噻吩。 step 4
Figure 02_image059
0.014 mol of ethyl 3-(4'-ethoxy-3,2',3'-trifluorobiphenyl-2-ylthio)propionate was mixed with 0.017 mol of 50 ml of THF at reflux temperature Potassium tert-butoxide was boiled together for 14 hours. The reaction mixture was mixed with water and MTB and worked up by extraction. The organic phase was concentrated and the product was isolated by column chromatography on silica gel with 1-chlorobutane to give 3-ethoxy-4,6-difluorodibenzothiophene.

步驟 5

Figure 02_image061
將0.013 mol之3-乙氧基-4,6-二氟二苯并噻吩溶解於50 ml之THF中,並在-70℃下逐滴添加11 ml (0.017 mol)之n-BuLi (1.6 M,於己烷中)。將混合物在-70℃下再攪拌30分鐘,且然後在相同溫度下添加0.017 mol之硼酸三甲酯(溶解於少量THF中)。使該反應混合物升溫至室溫,且然後添加2 ml之乙酸與2.5 ml之水之混合物。然後於最大45℃下逐滴添加3 ml之30%過氧化氫。再攪拌14小時後,將反應混合物與水及MTB混合並藉由萃取處理。濃縮有機相,並藉由管柱層析利用二氯甲烷在矽膠上分離產物,從而得到0.011 mol之7-乙氧基-4,6-二氟二苯并噻吩-3-醇。 step 5
Figure 02_image061
Dissolve 0.013 mol of 3-ethoxy-4,6-difluorodibenzothiophene in 50 ml of THF, and add 11 ml (0.017 mol) of n-BuLi (1.6 M , in hexane). The mixture was stirred at -70° C. for another 30 minutes, and then 0.017 mol of trimethyl borate (dissolved in a small amount of THF) was added at the same temperature. The reaction mixture was allowed to warm to room temperature, and then a mixture of 2 ml of acetic acid and 2.5 ml of water was added. Then 3 ml of 30% hydrogen peroxide were added dropwise at a maximum of 45°C. After stirring for a further 14 hours, the reaction mixture was mixed with water and MTB and worked up by extraction. The organic phase was concentrated and the product was separated by column chromatography on silica gel with dichloromethane to give 0.011 mol of 7-ethoxy-4,6-difluorodibenzothiophen-3-ol.

類似地製備以下化合物:

Figure 02_image063
The following compounds were prepared analogously:
Figure 02_image063

實例 2

Figure 02_image065
將9.9 g (30 mmol)之酚1 (類似於實例1製備)溶解於90 ml之DCM中並與8 ml之三乙胺及150 mg之DMAP混合。於5℃下添加8 ml (48 mmol)之三氟甲烷磺酸酐。隨後將批料攪拌1 h而不冷卻。將反應溶液置於矽膠上且用DCM溶析產物2 。產率:90%。 Example 2
Figure 02_image065
9.9 g (30 mmol) of phenol 1 (prepared analogously to Example 1) were dissolved in 90 ml of DCM and mixed with 8 ml of triethylamine and 150 mg of DMAP. 8 ml (48 mmol) of trifluoromethanesulfonic anhydride were added at 5°C. The batch was then stirred for 1 h without cooling. The reaction solution was placed on silica gel and the product 2 was eluted with DCM. Yield: 90%.

在保護氣體下,將13.9 g (30 mmol)之三氟甲磺酸酯2 與70 ml之甲苯、4.5 ml (73 mmol)之乙烷硫醇、10.5 g (76 mmol)之碳酸鉀、1.6 g (3.1 mmol)之雙(2-二苯基膦基苯基)醚及1.4 g (1.5 mmol)之參(二亞苄基丙酮)二鈀(0)混合並煮沸加熱過夜。經由Celite ®過濾冷卻之批料,濃縮並置於矽膠上。用正庚烷溶析產物3 。 熔點:73℃。 相: C 73 N (26) I (亦參見表)。Under protective gas, mix 13.9 g (30 mmol) of triflate 2 with 70 ml of toluene, 4.5 ml (73 mmol) of ethanethiol, 10.5 g (76 mmol) of potassium carbonate, 1.6 g (3.1 mmol) of bis(2-diphenylphosphinophenyl)ether and 1.4 g (1.5 mmol) of ginseng(dibenzylideneacetone)dipalladium(0) were mixed and boiled overnight. The cooled batch was filtered through Celite®, concentrated and placed on silica gel. Product 3 was eluted with n-heptane. Melting point: 73°C. Phase: C73N(26)I (see also table).

類似於實例1製備以下二苯并噻吩化合物:

Figure 02_image067
除非另有說明,否則基團R1/2 係直鏈的,即無支鏈。材料數據可參見表1。 表1.
Figure 107122722-A0304-12-0001-1
Figure 107122722-A0304-12-0002-5
*) 反式異構物The following dibenzothiophene compounds were prepared analogously to Example 1:
Figure 02_image067
Unless stated otherwise, the radical R 1/2 is linear, ie unbranched. Material data can be found in Table 1. Table 1.
Figure 107122722-A0304-12-0001-1
Figure 107122722-A0304-12-0002-5
*) trans isomer

類似於實例1製備以下二苯并呋喃化合物:

Figure 02_image069
除非另有說明,否則基團R1/2 係直鏈的,即無支鏈。材料數據可參見表2。 表2.
Figure 107122722-A0304-12-0002-4
Figure 107122722-A0304-12-0003-6
Figure 107122722-A0304-12-0004-7
*) 反式異構物The following dibenzofuran compounds were prepared analogously to Example 1:
Figure 02_image069
Unless stated otherwise, the radical R 1/2 is linear, ie unbranched. Material data can be found in Table 2. Table 2.
Figure 107122722-A0304-12-0002-4
Figure 107122722-A0304-12-0003-6
Figure 107122722-A0304-12-0004-7
*) trans isomer

其他化合物:

Figure 02_image071
Other compounds:
Figure 02_image071

Figure 107122722-A0101-11-0002-3
Figure 107122722-A0101-11-0002-3

Claims (15)

一種式I化合物,
Figure 107122722-A0305-02-0034-1
其中X 獨立地表示F或Cl,W表示S或O,m 表示0、1或2,R1及R2 彼此獨立地表示具有1至15個C原子之烷基或烷氧基,其中另外該等基團中之一或多個CH2基團在每一情形下彼此分別獨立以O原子不直接彼此連接之方式經-C≡C-、-CF2O-、-OCF2-、-CH=CH-、
Figure 107122722-A0305-02-0034-20
、-O-、-S-、-CO-O-或-O-CO-置換,且其中另外一或多個H原子可經鹵素置換,A1 在每一情形下獨立地表示選自以下之群之基團:a)1,4-伸苯基,其中另外一或兩個CH基團可經N置換且其中另外一或多個H原子可經基團L置換,b)由反式-1,4-伸環己基及1,4-伸環己烯基組成之群,其中另外一或多個不相鄰CH2基團可經-O-及/或-S-置換且其中另外一或多個H原子可經F或Cl置換,及c)由四氫吡喃-2,5-二基、1,3-二噁烷-2,5-二基、四氫呋喃-2,5-二基、環丁烷-1,3-二基、六氫吡啶-1,4-二基、噻吩-2,5-二基及硒吩-2,5-二基組成之群,其另外可經基團L單取代或多取代, L 在每次出現時獨立地表示F、Cl、CN、SCN、SF5或具有1至12個C原子之直鏈或具支鏈之在每一情形中視需要經氟化之烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰基氧基或烷氧基羰基氧基,且Z1 彼此獨立地表示單鍵、-CF2O-、-OCF2-、-CH2O-、-OCH2-、-(CO)O-、-O(CO)-、-(CH2)4-、-CH2CH2-、-CF2-CF2-、-CF2-CH2-、-CH2-CF2-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-(CH2)3O-、-O(CH2)3-、-C≡C-、-O-、-CH2-、-(CH2)3-或-CF2-。
A compound of formula I,
Figure 107122722-A0305-02-0034-1
wherein X independently represents F or Cl, W represents S or O, m represents 0, 1 or 2, R 1 and R 2 independently represent an alkyl or alkoxy group having 1 to 15 C atoms, wherein the other One or more of the CH2 groups in each case independently of each other via -C≡C-, -CF2O- , -OCF2- , -CH =CH-,
Figure 107122722-A0305-02-0034-20
, -O-, -S-, -CO-O- or -O-CO-, and wherein one or more additional H atoms may be replaced by a halogen, A 1 in each case independently represents one selected from the following Groups of groups: a) 1,4-phenylene, wherein one or two other CH groups can be replaced by N and one or more H atoms can be replaced by a group L, b) by trans- A group consisting of 1,4-cyclohexylene and 1,4-cyclohexenyl, wherein one or more non-adjacent CH 2 groups can be replaced by -O- and/or -S- and one of the other or multiple H atoms can be replaced by F or Cl, and c) from tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl The group consisting of cyclobutane-1,3-diyl, hexahydropyridine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, which can be additionally The group L is monosubstituted or polysubstituted, L independently at each occurrence represents F, Cl, CN, SCN, SF 5 or a straight-chain or branched chain having 1 to 12 C atoms in each case as desired Fluorinated alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, and Z 1 independently represent a single bond, -CF 2 O-, - OCF 2 -, -CH 2 O-, -OCH 2 -, -(CO)O-, -O(CO)-, -(CH 2 ) 4 -, -CH 2 CH 2 -, -CF 2 -CF 2 -, -CF 2 -CH 2 -, -CH 2 -CF 2 -, -CH=CH-, -CF=CF-, -CF=CH-, -CH=CF-, -(CH 2 ) 3 O- , -O(CH 2 ) 3 -, -C≡C-, -O-, -CH 2 -, -(CH 2 ) 3 - or -CF 2 -.
如請求項1之化合物,其中在該式I中,m具有值0。 The compound of claim 1, wherein in the formula I, m has a value of 0. 如請求項1之化合物,其中在該式I中R1 表示具有1至15個碳原子之未經取代烷基或烷氧基或具有2至15個C原子之烯基、烯基氧基或炔基,其在每一情形下視情況經單鹵化或多鹵化。 The compound as claimed in item 1, wherein in the formula I, R 1 represents an unsubstituted alkyl or alkoxy group with 1 to 15 carbon atoms or an alkenyl group with 2 to 15 C atoms, an alkenyloxy group or Alkynyl, which in each case is optionally monohalogenated or polyhalogenated. 如請求項1之化合物,其中在該式I中R2 表示具有1至7個碳原子之烷基或具有2至7個碳原子之烯基。 The compound of claim 1, wherein in the formula I, R 2 represents an alkyl group with 1 to 7 carbon atoms or an alkenyl group with 2 to 7 carbon atoms. 如請求項1至4中任一項之化合物,其中在該式I中W 表示S。 The compound according to any one of claims 1 to 4, wherein W in the formula I represents S. 如請求項1之化合物,其中該等式I化合物係選自子式IA至IC及ID至IF
Figure 107122722-A0305-02-0036-3
Figure 107122722-A0305-02-0036-4
Figure 107122722-A0305-02-0036-5
Figure 107122722-A0305-02-0036-6
Figure 107122722-A0305-02-0036-7
Figure 107122722-A0305-02-0036-8
其中R1、R2、A1及Z1具有如針對如請求項1之式I的含義,其中此處之Z1不表示單鍵。
A compound as claimed in item 1, wherein the compound of formula I is selected from sub-formulas IA to IC and ID to IF
Figure 107122722-A0305-02-0036-3
Figure 107122722-A0305-02-0036-4
Figure 107122722-A0305-02-0036-5
Figure 107122722-A0305-02-0036-6
Figure 107122722-A0305-02-0036-7
Figure 107122722-A0305-02-0036-8
Wherein R 1 , R 2 , A 1 and Z 1 have the same meanings as for formula I as claimed in claim 1, wherein Z 1 here does not represent a single bond.
如請求項1之化合物,其中該等化合物係選自式IA-1至IA-3及ID-1至ID-3之化合物,
Figure 107122722-A0305-02-0037-9
Figure 107122722-A0305-02-0037-10
Figure 107122722-A0305-02-0037-11
Figure 107122722-A0305-02-0037-12
Figure 107122722-A0305-02-0037-13
Figure 107122722-A0305-02-0037-14
其中烷基及烷基*彼此獨立地表示具有1至7個C原子之直鏈烷基且烷氧基獨立地表示具有1至7個C原子之直鏈烷氧基。
As the compound of claim 1, wherein these compounds are selected from the compounds of formula IA-1 to IA-3 and ID-1 to ID-3,
Figure 107122722-A0305-02-0037-9
Figure 107122722-A0305-02-0037-10
Figure 107122722-A0305-02-0037-11
Figure 107122722-A0305-02-0037-12
Figure 107122722-A0305-02-0037-13
Figure 107122722-A0305-02-0037-14
wherein alkyl and alkyl* independently represent straight-chain alkyl having 1 to 7 C atoms, and alkoxy independently represent straight-chain alkoxy having 1 to 7 C atoms.
如請求項1至4中任一項之化合物,其中X 表示F。 The compound according to any one of claims 1 to 4, wherein X represents F. 如請求項1至4及6中任一項之化合物,其中 R1 表示具有1至7個碳原子之烷氧基。 The compound according to any one of claims 1 to 4 and 6, wherein R 1 represents an alkoxy group having 1 to 7 carbon atoms. 如請求項1、3及4中任一項之化合物,其中m=1或2,且環A1在每一情形下係獨立地選自以下部分
Figure 107122722-A0305-02-0038-15
A compound as claimed in any one of claims 1, 3 and 4, wherein m= 1 or 2, and ring A is in each case independently selected from the following moieties
Figure 107122722-A0305-02-0038-15
一種如請求項1至10中任一項之化合物之用途,其用於液晶介質。 A use of the compound according to any one of claims 1 to 10 in liquid crystal media. 一種包含至少兩種化合物之液晶介質,其特徵在於其包含至少一種如請求項1至10中任一項之化合物。 A liquid-crystalline medium comprising at least two compounds, characterized in that it comprises at least one compound according to any one of claims 1 to 10. 一種光電顯示元件,其含有如請求項12之液晶介質。 An optoelectronic display element, which contains the liquid crystal medium as claimed in claim 12. 如請求項13之光電顯示元件,其使用聚合物穩定或聚合物誘導之液晶排列。 The photoelectric display device according to claim 13, which uses polymer-stabilized or polymer-induced liquid crystal alignment. 一種製備如請求項1至10中任一項之式I化合物之方法,其特徵在於其包括如下方法步驟:其中使式(B)之化合物
Figure 107122722-A0305-02-0039-17
其中W、X、Z1、A1、m及R1獨立地如請求項1至9中任一項之式I中所定義,在OH基團與三氟甲磺酸或其反應性衍生物反應,以得到式(C)化合物
Figure 107122722-A0305-02-0039-19
其中獨立地OTf 表示基團O(SO2)CF3,且W、X、Z1、A1、m及R1獨立地如請求項1至9中任一項之式I中所定義,且於另一方法步驟中,轉化成該式I化合物。
A method for preparing a compound of formula I as any one of claims 1 to 10, characterized in that it comprises the following method steps: wherein the compound of formula (B)
Figure 107122722-A0305-02-0039-17
Wherein W, X, Z 1 , A 1 , m and R 1 are independently as defined in formula I of any one of claims 1 to 9, in the OH group and trifluoromethanesulfonic acid or its reactive derivatives Reaction, to obtain formula (C) compound
Figure 107122722-A0305-02-0039-19
wherein independently OTf represents the group O(SO 2 )CF 3 , and W, X, Z 1 , A 1 , m and R 1 are independently as defined in formula I of any one of claims 1 to 9, and In a further process step, the compound of formula I is converted.
TW107122722A 2017-07-03 2018-07-02 Thioether derivatives of dibenzothiophene and dibenzofuran TWI787298B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017006284.6 2017-07-03
DE102017006284.6A DE102017006284A1 (en) 2017-07-03 2017-07-03 Thioether derivatives of dibenzothiophene and dibenzofuran
??102017006284.6 2017-07-03

Publications (2)

Publication Number Publication Date
TW201906830A TW201906830A (en) 2019-02-16
TWI787298B true TWI787298B (en) 2022-12-21

Family

ID=62837900

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107122722A TWI787298B (en) 2017-07-03 2018-07-02 Thioether derivatives of dibenzothiophene and dibenzofuran

Country Status (4)

Country Link
CN (1) CN110831931B (en)
DE (2) DE102017006284A1 (en)
TW (1) TWI787298B (en)
WO (1) WO2019007821A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4209567B1 (en) * 2018-09-27 2024-08-14 Merck Patent GmbH Liquid-crystal medium
EP3666853B1 (en) * 2018-12-10 2021-06-16 Merck Patent GmbH Liquid-crystal medium
CN112195030B (en) * 2020-09-14 2022-04-15 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing tetrahydropyran and terphenyl and application thereof
CN115216305A (en) * 2021-04-15 2022-10-21 江苏和成显示科技有限公司 Liquid crystal composition and liquid crystal display device thereof
CN115247067B (en) * 2021-04-27 2024-04-23 江苏和成显示科技有限公司 Liquid crystal compound, liquid crystal composition thereof and liquid crystal display device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200720408A (en) * 2005-08-09 2007-06-01 Merck Patent Gmbh Liguid-crystalline medium
TW200932735A (en) * 2007-11-27 2009-08-01 Merck Patent Gmbh Benzo[f]chromene and pyrano[3,2-f]chromene derivatives
TW201620892A (en) * 2014-04-22 2016-06-16 馬克專利公司 4,6-difluorodibenzothiophene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10101022A1 (en) 2001-01-11 2002-07-18 Clariant Internat Ltd Muttenz Fluorinated aromatics and their use in liquid crystal mixtures
DE102005012585A1 (en) 2004-04-14 2005-11-03 Merck Patent Gmbh New dibenzofuran-, dibenzothiophene- and fluorene derivatives useful in liquid crystalline media, which is useful in e.g. electro optical display elements
EP3327011B1 (en) 2014-03-17 2020-03-25 Merck Patent GmbH 4,6-difluor-dibenzofurane derivatives
EP3085753B1 (en) * 2015-04-13 2019-04-24 Merck Patent GmbH Fluorinated dibenzofurane derivatives and dibenzothiophene derivatives
US10671121B2 (en) * 2018-09-14 2020-06-02 Apple Inc. Magnetic layout in electronic devices and accessory devices for electronic devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200720408A (en) * 2005-08-09 2007-06-01 Merck Patent Gmbh Liguid-crystalline medium
TW200932735A (en) * 2007-11-27 2009-08-01 Merck Patent Gmbh Benzo[f]chromene and pyrano[3,2-f]chromene derivatives
TW201620892A (en) * 2014-04-22 2016-06-16 馬克專利公司 4,6-difluorodibenzothiophene derivatives

Also Published As

Publication number Publication date
DE112018003408A5 (en) 2020-03-12
WO2019007821A1 (en) 2019-01-10
TW201906830A (en) 2019-02-16
CN110831931B (en) 2023-06-16
CN110831931A (en) 2020-02-21
DE102017006284A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
JP6552254B2 (en) 4,6-difluorodibenzothiophene derivatives
JP6526990B2 (en) 4,6-Difluorodibenzofuran derivatives
JP6797544B2 (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
KR102565571B1 (en) Dibenzofuran derivatives and dibenzothiophene derivatives
TWI787298B (en) Thioether derivatives of dibenzothiophene and dibenzofuran
JP6137419B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
JP2003176251A (en) Liquid crystalline compound
TWI734872B (en) Monofluorinated cyclohexanes
JP2007039642A (en) Difluorobenzene derivative and liquid crystal composition by using the same
JP2003183285A (en) Oxabicyclooctane
TWI757383B (en) Thioether compounds